Format

Send to

Choose Destination
Nat Rev Cancer. 2002 Jan;2(1):59-65.

Immune evasion in human papillomavirus-associated cervical cancer.

Author information

1
Sir Albert Sakzewski Virus Research Centre, Royal Children's Hospital, Herston, Australia. r.tindle@mailbox.uq.edu.au

Abstract

Tumour-associated viruses produce antigens that, on the face of it, are ideal targets for immunotherapy. Unfortunately, these viruses are experts at avoiding or subverting the host immune response. Cervical-cancer-associated human papillomavirus (HPV) has a battery of immune-evasion mechanisms at its disposal that could confound attempts at HPV-directed immunotherapy. Other virally associated human cancers might prove similarly refractive to immuno-intervention unless we learn how to circumvent their strategies for immune evasion.

PMID:
11902586
DOI:
10.1038/nrc700
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center